02/25 | CARA : 4Q Earnings Snapshot | AQ |
02/25 | CARA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
02/25 | CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8.. | AQ |
02/25 | CARA THERAPEUTICS : Reports Fourth Quarter and Full Year 2020 Financial Results | AQ |
02/18 | Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Res.. | GL |
01/12 | CARA THERAPEUTICS : Initiates Phase 2 Trial of Oral KORSUVA for the Treatment o.. | AQ |
01/11 | Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Prur.. | GL |
01/06 | CARA THERAPEUTICS : to Present at the 39th Annual J.P. Morgan Healthcare Confer.. | AQ |
2020 | CARA THERAPEUTICS : Submits New Drug Application to U.S. Food and Drug Administ.. | AQ |
2020 | CARA THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Ex.. | AQ |
2020 | Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administ.. | GL |
2020 | CARA THERAPEUTICS : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Secon.. | PR |
2020 | CARA THERAPEUTICS : Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR.. | AQ |
2020 | Cara Therapeutics Completes Full Enrollment in KARE Phase 2 Trial of Oral KOR.. | GL |
2020 | CARA THERAPEUTICS : to Present at Multiple Upcoming Investor Conferences | AQ |
2020 | Cara Therapeutics to Present at Multiple Upcoming Investor Conferences | GL |
2020 | CARA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
2020 | CARA : 3Q Earnings Snapshot | AQ |
2020 | CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
2020 | CARA THERAPEUTICS : Reports Third Quarter 2020 Financial Results | AQ |
2020 | Cara Therapeutics Reports Third Quarter 2020 Financial Results | GL |
2020 | CARA THERAPEUTICS : to Announce Third Quarter 2020 Financial Results on Novembe.. | AQ |
2020 | Cara Therapeutics to Announce Third Quarter 2020 Financial Results on Novembe.. | GL |
2020 | CARA THERAPEUTICS : SWK Holdings' Subsidiary, Enteris BioPharma, Receives Miles.. | PR |
2020 | CARA THERAPEUTICS : Announces Presentation at American Society of Nephrology Ki.. | AQ |
2020 | CARA THERAPEUTICS : Announces Presentation at American Society of Nephrology Ki.. | AQ |
2020 | Cara Therapeutics Announces Presentation at American Society of Nephrology Ki.. | GL |
2020 | CARA THERAPEUTICS : Vifor pharma and cara therapeutics sign us license agreemen.. | AQ |
2020 | Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva t.. | AQ |
2020 | CARA THERAPEUTICS : and Vifor Pharma License Agreement Presentation | PU |
2020 | CARA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregiste.. | AQ |
2020 | CARA THERAPEUTICS : Vifor Pharma and Cara Therapeutics sign US license agreemen.. | AQ |
2020 | Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva&.. | GL |
2020 | TITAN PHARMACEUTICALS : Provides a Strategic and Corporate Update | AQ |
2020 | CARA THERAPEUTICS : Appoints Thomas Reilly as Chief Financial Officer | AQ |
2020 | CARA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation.. | AQ |
2020 | CARA THERAPEUTICS : Appoints Thomas Reilly as Chief Financial Officer | AQ |
2020 | Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer | GL |
2020 | CARA THERAPEUTICS : Submission of Matters to a Vote of Security Holders (form 8.. | AQ |
2020 | CARA : 2Q Earnings Snapshot | AQ |
2020 | CARA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
2020 | CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
2020 | Cara Therapeutics Reports Second Quarter 2020 Financial Results | GL |
2020 | Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conf.. | GL |
2020 | Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August.. | GL |
2020 | CARA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
2020 | Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff,.. | GL |
2020 | CARA THERAPEUTICS : Announces Completion of Interim Statistical Assessment for .. | AQ |
2020 | CARA THERAPEUTICS, INC. : Other Events (form 8-K) | AQ |
2020 | Cara Therapeutics Announces Completion of Interim Statistical Assessment for .. | GL |
2020 | CARA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (.. | AQ |
2020 | CARA THERAPEUTICS : 4 | PU |
2020 | Cara Therapeutics to Present at the Jefferies Virtual Healthcare Conference | GL |
2020 | CARA : 1Q Earnings Snapshot | AQ |
2020 | CARA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
2020 | CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition (form 8.. | AQ |
2020 | Cara Therapeutics Reports First Quarter 2020 Financial Results | GL |
2020 | Cara Therapeutics to Present at the Virtual BofA Securities 2020 Health Care .. | GL |
2020 | Cara Therapeutics to Announce First Quarter 2020 Financial Results on May 11,.. | GL |
2020 | CARA THERAPEUTICS : VFMCRP and Cara Therapeutics announce positive results from.. | AQ |
2020 | Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi.. | AQ |
2020 | CARA THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Sta.. | AQ |
2020 | CARA THERAPEUTICS : VFMCRP and Cara Therapeutics announce positive results from.. | BU |
2020 | Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma Announce Posi.. | GL |
2020 | Cara Therapeutics to Present at the Virtual 19th Annual Needham Healthcare Co.. | GL |
2020 | CARA THERAPEUTICS, INC. : Other Events (form 8-K) | AQ |
2020 | Cara Therapeutics Reports Clinical Updates | GL |
2020 | CARA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition.. | AQ |
2020 | CARA : 4Q Earnings Snapshot | AQ |
2020 | CARA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financ.. | AQ |
2020 | Cara Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results | GL |
2020 | Cara Therapeutics to Announce Fourth Quarter and Full Year 2019 Financial Res.. | GL |
2020 | CARA THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K) | AQ |
2020 | CARA THERAPEUTICS : to Present at the 38th Annual J.P. Morgan Healthcare Confer.. | AQ |
2019 | CARA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |